Health Authorities Prepare for Unusual and Widespread Monkeypox Outbreak
Health authorities gear up to respond to an ’unusual’ and widespread outbreak of monkeypox, implementing surveillance, vaccination strategies, and public health interventions to contain the spread of the virus and mitigate its impact.
Februery 2023
COVID-19 Vaccine Demonstrates Efficacy Across Body Weights, Large-scale Study Suggests
A study involving 9 million adults in England indicates that COVID-19 vaccination provides protection against hospitalization and death across all body weights, underscoring the importance of vaccination in mitigating the impact of the pandemic irrespective of weight status.
January 2023
BCG Revaccination Safety and Efficacy Examined in Relation to COVID-19 Morbidity in Healthcare Workers
Safety and efficacy of BCG revaccination are investigated in relation to COVID-19 morbidity in healthcare workers, providing insights into the potential protective effects of BCG vaccination against severe outcomes of COVID-19.
January 2023
FDA Authorizes Moderna and Pfizer-BioNTech Vaccines for Children 6 Months and Older
The FDA grants authorization for the use of Moderna and Pfizer-BioNTech COVID-19 vaccines in children aged 6 months and older, citing favorable risk-benefit profiles and the urgency of vaccinating pediatric populations.
January 2023
Vaccine Equity Imperative to Prevent Emergence of New COVID-19 Variants, WHO Warns
Dr. Tedros Adhanom Ghebreyesus underscores the importance of vaccine equity in preventing the emergence of new COVID-19 variants, citing the global population’s vulnerability to ongoing transmission due to inadequate vaccination coverage.
January 2023
Certain Common Inflammatory Immune Conditions Linked to Higher COVID-19 Death Rate Pre-Vaccination
Pre-vaccination, individuals with certain common inflammatory immune conditions face a higher death rate from COVID-19, highlighting the need for targeted preventive measures and vaccination strategies in vulnerable populations.
January 2023
Europe on Alert for Monkeypox Cases, WHO Advises Control Measures
Europe remains on high alert for cases of monkeypox, with the WHO emphasizing the importance of implementing control measures despite the absence of specific treatments or vaccines, underscoring the need for proactive surveillance and response efforts.
January 2023
WHO Approves Single-Dose CanSinoBIO COVID-19 Vaccine
The WHO approves the CanSinoBIO single-dose COVID-19 vaccine, Convidecia, for emergency use, highlighting its potential as both a primary immunization and heterologous booster, with the added advantage of storage at standard refrigeration temperatures.
January 2023
